Yoneshige Azusa, Hagiyama Man, Takashima Yasutoshi, Ueno Satoru, Inoue Takao, Kimura Ryuichiro, Koriyama Yoshiki, Ito Akihiko
Department of Pathology, Faculty of Medicine, Kindai University, Osaka, Japan.
Department of Ophthalmology, Faculty of Medicine, Kindai University, Osaka, Japan.
Front Cell Dev Biol. 2021 May 31;9:664327. doi: 10.3389/fcell.2021.664327. eCollection 2021.
Elevation of intraocular pressure is a major risk factor for glaucoma development, which causes the loss of retinal ganglion cells (RGCs). Lipocalin 2 (Lcn2) is upregulated in glaucomatous retinae; however, whether Lcn2 is directly involved in glaucoma is debated. In this study, retinal explant cultures were subjected to increased water pressure using a two-chamber culture device, and Lcn2 protein levels were examined by immunoblotting. TdT-mediated dUTP nick and labeling (TUNEL) and glial fibrillary acidic protein (GFAP) immunohistochemical assays were performed to assess apoptosis and gliosis, respectively. The neurotoxicity of Lcn2 in the retinal explant culture was determined with exogenous administration of recombinant Lcn2. The Lcn2 protein levels, percentage of TUNEL-positive cells, and GFAP-positive area were significantly higher in retinae cultured under 50 cm HO pressure loads compared to those cultured under 20 cm HO. We found that Lcn2 exhibited neurotoxicity in retinae at dose of 1 μg/ml. The negative effects of increased hydrostatic pressure were attenuated by the iron chelator deferoxamine. This is the first report demonstrating the direct upregulation of Lcn2 by elevating hydrostatic pressure. Modulating Lcn2 and iron levels may be a promising therapeutic approach for retinal degeneration.
眼压升高是青光眼发展的主要危险因素,青光眼会导致视网膜神经节细胞(RGCs)丧失。脂质运载蛋白2(Lcn2)在青光眼视网膜中上调;然而,Lcn2是否直接参与青光眼仍存在争议。在本研究中,使用双室培养装置对视网膜外植体培养物施加增加的水压,并通过免疫印迹检测Lcn2蛋白水平。分别进行TdT介导的dUTP缺口末端标记(TUNEL)和胶质纤维酸性蛋白(GFAP)免疫组织化学分析以评估细胞凋亡和胶质增生。通过外源性给予重组Lcn2来确定Lcn2在视网膜外植体培养中的神经毒性。与在20 cm水柱压力负荷下培养的视网膜相比,在50 cm水柱压力负荷下培养的视网膜中Lcn2蛋白水平、TUNEL阳性细胞百分比和GFAP阳性面积显著更高。我们发现Lcn2在1μg/ml剂量下对视网膜表现出神经毒性。铁螯合剂去铁胺减轻了静水压力增加的负面影响。这是第一份证明通过提高静水压力直接上调Lcn2的报告。调节Lcn2和铁水平可能是一种有前景的视网膜变性治疗方法。